Krystal Biotech, Inc. (KRYS) Net margin 2023–2025
Krystal Biotech, Inc. (KRYS) net profit margin by fiscal year — reported net income divided by reported revenue.
52.6%FY2025 · since FY2023: 21.6% → 52.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 52.6% | +21.9 pp |
| FY2024 | 30.7% | +9.1 pp |
| FY2023 | 21.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice